|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$11.15 |
$11.34 |
$10.92 |
$11.34 |
138.90K | 04/22/2024 |
$11.37 |
$11.71 |
$11.22 |
$11.34 |
168.20K | 04/23/2024 |
$11.31 |
$11.87 |
$10.92 |
$11.00 |
305.00K | 04/24/2024 |
$11.07 |
$11.21 |
$10.19 |
$10.19 |
404.70K | 04/25/2024 |
$10.20 |
$10.21 |
$9.34 |
$9.39 |
847.50K |
|
Adverum Biotechnologies is a clinical-stage company focused on establishing gene therapy as a standard of care for ocular diseases. Co.'s main product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration who are responsive to anti-vascular endothelial growth factor therapy. Co.'s second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy via a single IVT injection. | |
|
Adverum Biotechnologies (ADVM) has the following price history information. Looking back at ADVM historical stock prices for the last five trading days, on April 19, 2024, ADVM opened at $11.15, traded as high as $11.34 and as low as $10.92, and closed at $11.34. Trading volume was a total of 138.90K shares. On April 22, 2024, ADVM opened at $11.37, traded as high as $11.71 and as low as $11.22, and closed at $11.34. Trading volume was a total of 168.20K shares. On April 23, 2024, ADVM opened at $11.31, traded as high as $11.87 and as low as $10.92, and closed at $11.00. Trading volume was a total of 305.00K shares. On April 24, 2024, ADVM opened at $11.07, traded as high as $11.21 and as low as $10.19, and closed at $10.19. Trading volume was a total of 404.70K shares. On April 25, 2024, ADVM opened at $10.20, traded as high as $10.21 and as low as $9.34, and closed at $9.39. Trading volume was a total of 847.50K shares.
ADVM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adverum Biotechnologies shares, starting with a $10,000 purchase of ADVM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/01/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$251.60 |
|
End price/share: |
$9.39 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-96.27% |
|
Average Annual Total Return: |
-28.65% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$373.33 |
|
Years: |
9.74 |
|
|
|
Date |
Close |
04/19/2024 | $11.34 | 04/22/2024 | $11.34 | 04/23/2024 | $11.00 | 04/24/2024 | $10.19 | 04/25/2024 | $9.39 |
|
|